Delivery Order SPE2DR25D3011-SPE2DR26FW38E
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $88,906.40 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, designated as a firm fixed-price delivery order, was awarded on January 6, 2026, with an ultimate completion date of January 28, 2026. The vendor will perform the work at its corporate office location in Conshohocken, Pennsylvania. This non-competitive delivery order was issued without a set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a delivery order valued at $6,667.98 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on January 5, 2026, is a firm fixed price delivery order with an ultimate completion date of January 27, 2026. The award carries no set-aside designation, indicating competitive selection. AmerisourceBergen will perform the contract at its corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents under a firm fixed-price contract valued at $1,032.11. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 16, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,032.11 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 29, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $181,109.12 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price, competitively awarded delivery order is scheduled for completion by November 12, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, reflecting AmerisourceBergen's competitive standing within the federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,244.98 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The award, issued on January 7, 2026, is scheduled for completion by January 29, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. This delivery order is issued under AmerisourceBergen's parent company...
- The Defense Logistics Agency has awarded a delivery order valued at $30,963.30 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 5, 2025, carries a firm fixed price and has an ultimate completion date of August 26, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside contract awarded through competitive procurement, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents under a firm fixed-price contract valued at $1,122.49. The award, issued on January 5, 2026, with an ultimate completion date of January 27, 2026, represents a non-competitive, direct procurement leveraging the company's existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $7,437.12 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract is a firm fixed price delivery order with an ultimate completion date of September 29, 2025, and was awarded on September 8, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This is a competitive award with no set-aside designation. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,020.70 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on December 10, 2025, with an ultimate completion date of January 2, 2026, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete in the...
- SPE2DR25D3011Indefinite Delivery Contract
- SPE2DR25D3011-SPE2DR26FW38EDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $96,814.96 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract was competitively awarded on January 6, 2026, with an ultimate completion date of January 28, 2026, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will occur at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary $999,999,999.00 IDC with DLA through December 2031 and serves as a critical pharmaceutical distributor for federal military healthcare programs. The IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies, including vaccines, specialty medications, and generic drugs to support military treatment facilities and other federal healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $96.8k | 1/5/26 |